• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Tumbles 150 Points; McDonald's Sales Miss Views

    2/5/24 10:01:16 AM ET
    $CHEA
    $DMK
    $FDMT
    $INBS
    Blank Checks
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CHEA alert in real time by email

    U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Monday.

    Following the market opening Monday, the Dow traded down 0.41% to 38,494.03 while the NASDAQ fell 0.15% to 15,605.04. The S&P 500 also fell, dropping, 0.18% to 4,949.49.

    Check This Out: Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday

     

    Leading and Lagging Sectors

     

    Health care shares rose by 0.6% on Monday.

    In trading on Monday, materials shares fell by 2.4%.

     

    Top Headline

     

    McDonald’s Corporation (NYSE:MCD) posted weaker-than-expected sales for its fourth quarter.

    McDonald’s reported adjusted EPS of $2.95, beating the consensus of $2.82. Sales of $6.41 billion, up 8% Y/Y (6% in constant currencies), fell slightly short of the consensus of $6.45 billion.

     

    Equities Trading UP

     

    Yield10 Bioscience, Inc. (NASDAQ:YTEN) shares shot up 104% to $0.4673.

    Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) got a boost, surging 91% to $33.42 after the company announced interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet AMD patients with severe disease activity and a high treatment burden.

    Chenghe Acquisition Co. (NASDAQ:CHEA) shares were also up, gaining 82% to $9.99 after shareholders on Friday voted to approve the merger agreement with Taiwan Color Optics.

     

    Equities Trading DOWN

     

    NanoString Technologies, Inc. (NASDAQ:NSTG) shares dropped 73% to $0.1260 after the company initiated voluntary Chapter 11 restructuring proceedings.

    Shares of DMK Pharmaceuticals Corporation (NASDAQ:DMK) were down 44% to $0.29. The company filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.

    Intelligent Bio Solutions Inc. (NASDAQ:INBS) was down, falling 38% to $3.7140 after the company announced exercise of previously issued warrants for $1.77 million in gross proceeds.

    Also Check This Out: How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q4 Earnings Report

     

    Commodities

     

    In commodity news, oil traded down 0.7% to $71.79 while gold traded down 1% at $2,033.60.

    Silver traded down 1.7% to $22.405 on Monday while copper fell 1.3% to $3.7705.

     

    Euro zone

     

    European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.1%, London’s FTSE 100 fell 0.1% while Spain’s IBEX 35 Index fell 0.9% The German DAX fell 0.1% French CAC 40 fell 0.2% while Italy’s FTSE MIB Index rose 0.7%.

    The HCOB Eurozone services PMI declined to 48.4 in January versus 48.8 in the prior month, while composite PMI surged to a six-month high of 47.9 in January. The HCOB Germany Services PMI rose to 47.7 in January versus a preliminary reading of 47.6, while France services PMI was revised higher to 45.4 in January compared to a preliminary level of 45.

    New car registrations in the UK rose by 8.2% year-over-year to 142,876 units in January. The United Kingdom's unemployment rate fell to 3.9% during the three months leading up to November.

     

    Asia Pacific Markets

     

    Asian markets closed mostly lower on Monday, with Japan’s Nikkei 225 gaining 0.54%, Hong Kong’s Hang Seng Index falling 0.15% and China’s Shanghai Composite Index falling 1.02%. India’s S&P BSE Sensex, meanwhile, fell 0.49%.

    The HSBC India services PMI rose to 61.8 in January compared to a preliminary reading of 61.2. The Caixin China General service PMI fell to 52.7 in January compared to December’s reading of 52.9.

    The S&P Global Hong Kong SAR PMI declined to 49.9 in January versus 51.3 in December. The au Jibun Bank Japan services PMI rose to 53.1 in January compared to a preliminary reading of 52.7.

     

    Economics

     

    The S&P Global US services PMI was revised lower to 52.5 in January compared to the preliminary reading of 52.9.

    The S&P Global US Composite PMI slipped to 52.0 in January, versus the preliminary reading of 52.3.

    Now Read This: Top 5 Consumer Stocks That Could Blast Off In Q1

    Get the next $CHEA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CHEA
    $DMK
    $FDMT
    $INBS

    CompanyDatePrice TargetRatingAnalyst
    McDonald's Corporation
    $MCD
    2/2/2026$360.00Neutral → Buy
    BTIG Research
    4D Molecular Therapeutics Inc.
    $FDMT
    1/28/2026$33.00Overweight
    Barclays
    McDonald's Corporation
    $MCD
    1/7/2026$355.00Perform → Outperform
    Oppenheimer
    4D Molecular Therapeutics Inc.
    $FDMT
    11/7/2025Underweight → Equal-Weight
    Morgan Stanley
    McDonald's Corporation
    $MCD
    10/28/2025$300.00Neutral
    Mizuho
    McDonald's Corporation
    $MCD
    10/22/2025$360.00 → $362.00Overweight
    Barclays
    McDonald's Corporation
    $MCD
    10/9/2025$320.00Sector Perform
    RBC Capital Mkts
    McDonald's Corporation
    $MCD
    7/14/2025$250.00Sell
    Melius
    More analyst ratings

    $CHEA
    $DMK
    $FDMT
    $INBS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Daniel Kareem bought $40,074 worth of shares (145 units at $276.37) (SEC Form 4)

    4 - MCDONALDS CORP (0000063908) (Issuer)

    2/14/25 4:27:56 PM ET
    $MCD
    Restaurants
    Consumer Discretionary

    Schuler Jack W bought $497,250 worth of shares (765,000 units at $0.65) (SEC Form 4)

    4 - YIELD10 BIOSCIENCE, INC. (0001121702) (Issuer)

    10/10/23 4:41:49 PM ET
    $YTEN

    $CHEA
    $DMK
    $FDMT
    $INBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, McDonald's USA Erlinger Joseph M. exercised 2,626 shares at a strike of $157.79 and sold $854,106 worth of shares (2,626 units at $325.25) (SEC Form 4)

    4 - MCDONALDS CORP (0000063908) (Issuer)

    2/11/26 3:53:41 PM ET
    $MCD
    Restaurants
    Consumer Discretionary

    President, McDonald's USA Erlinger Joseph M. exercised 2,626 shares at a strike of $157.79 and sold $805,079 worth of shares (2,626 units at $306.58) (SEC Form 4)

    4 - MCDONALDS CORP (0000063908) (Issuer)

    1/13/26 1:19:01 PM ET
    $MCD
    Restaurants
    Consumer Discretionary

    SEC Form 4 filed by Director Sblendorio Glenn

    4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)

    1/7/26 9:12:50 PM ET
    $FDMT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CHEA
    $DMK
    $FDMT
    $INBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year

    First half fiscal 2026 revenue surpasses $2 million, up 36% year-over-year  Reader sales more than double to 104% year-over-year for the second quarter, demonstrating razor-razorblade model momentum Gross profit margins for first half fiscal 2026 increased 10% year-over-year to 49%, reflecting improved operational efficiency Current assets balance of $12.17 million as of December 31, 2025, including $9.40 million receivable in connection with the private placement of securities that closed on January 2, 2026. NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, no

    2/12/26 8:30:00 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    McDONALD'S REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

    Global comparable sales in the fourth quarter increased 5.7%, with positive global comparable guest counts and strong comparable sales growth across all segmentsGlobal Systemwide sales* for the full year increased 7% (5% in constant currencies) to over $139 billion, or growth of $9 billion ($7 billion in constant currencies)Across 70 loyalty markets, Systemwide sales to loyalty members for the full year increased 20% to nearly $37 billion, with 90-day active loyalty users up 19% to nearly 210 million as of year-endCHICAGO, Feb. 11, 2026 /PRNewswire/ -- McDonald's Corporation today announced results for the fourth quarter and year ended December 31, 2025. "McDonald's value leadership is work

    2/11/26 4:01:00 PM ET
    $MCD
    Restaurants
    Consumer Discretionary

    James D. Farley, Jr. Elected to McDonald's Board of Directors

    CHICAGO, Feb. 10, 2026 /PRNewswire/ -- McDonald's Corporation (NYSE:MCD) today announced the election of James D. Farley, Jr., to its Board of Directors, effective February 4, 2026.  Mr. Farley currently serves as President and CEO of Ford Motor Company and sits on Ford's Board of Directors, where he is guiding the company's Ford+ transformation, a strategy centered on digital innovation, customer-centric design, and operational modernization. He brings more than 30 years of experience leading complex global organizations and transforming iconic consumer brands. He previously

    2/10/26 9:15:00 AM ET
    $MCD
    Restaurants
    Consumer Discretionary

    $CHEA
    $DMK
    $FDMT
    $INBS
    SEC Filings

    View All

    Intelligent Bio Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    2/12/26 8:55:44 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Intelligent Bio Solutions Inc.

    10-Q - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    2/12/26 8:31:15 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    McDonald's Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MCDONALDS CORP (0000063908) (Filer)

    2/11/26 4:02:36 PM ET
    $MCD
    Restaurants
    Consumer Discretionary

    $CHEA
    $DMK
    $FDMT
    $INBS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    McDonald's upgraded by BTIG Research with a new price target

    BTIG Research upgraded McDonald's from Neutral to Buy and set a new price target of $360.00

    2/2/26 6:47:28 AM ET
    $MCD
    Restaurants
    Consumer Discretionary

    Barclays resumed coverage on 4D Molecular Therapeutics with a new price target

    Barclays resumed coverage of 4D Molecular Therapeutics with a rating of Overweight and set a new price target of $33.00

    1/28/26 7:14:57 AM ET
    $FDMT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    McDonald's upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded McDonald's from Perform to Outperform and set a new price target of $355.00

    1/7/26 8:44:57 AM ET
    $MCD
    Restaurants
    Consumer Discretionary

    $CHEA
    $DMK
    $FDMT
    $INBS
    Leadership Updates

    Live Leadership Updates

    View All

    James D. Farley, Jr. Elected to McDonald's Board of Directors

    CHICAGO, Feb. 10, 2026 /PRNewswire/ -- McDonald's Corporation (NYSE:MCD) today announced the election of James D. Farley, Jr., to its Board of Directors, effective February 4, 2026.  Mr. Farley currently serves as President and CEO of Ford Motor Company and sits on Ford's Board of Directors, where he is guiding the company's Ford+ transformation, a strategy centered on digital innovation, customer-centric design, and operational modernization. He brings more than 30 years of experience leading complex global organizations and transforming iconic consumer brands. He previously

    2/10/26 9:15:00 AM ET
    $MCD
    Restaurants
    Consumer Discretionary

    NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

    Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 ProgramThe ability to attract seasoned ophthalmology leaders highlights the compelling opportunity for VIS-101, and underscores our commitment to assembling a world-class teamVIS-101, a novel bifunctional biologic targeting VEGF-A/ANG2, has the potential to become the current standard for wet AMD, DME and RVO, and is expected to be Phase-3-ready in 2026 ROCKVILLE, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (NASDAQ:NBP) (NovaBridge or the Company) a global biotechnology platform compa

    11/20/25 8:00:00 PM ET
    $AURA
    $FDMT
    $NBP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    4DMT Appoints Kristian Humer as Chief Financial Officer

    EMERYVILLE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced the appointment of Kristian Humer as Chief Financial Officer. Mr. Humer will lead the Company's financial strategy and operations, including responsibility for financial planning, capital allocation, corporate development and supporting strategic initiatives. Mr. Humer is an accomplished finance executive and biotechnology leader with more than two decades of experience

    11/17/25 6:00:00 AM ET
    $FDMT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CHEA
    $DMK
    $FDMT
    $INBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 4D Molecular Therapeutics Inc.

    SC 13G/A - 4D Molecular Therapeutics, Inc. (0001650648) (Subject)

    11/15/24 5:05:27 PM ET
    $FDMT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Intelligent Bio Solutions Inc.

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    11/14/24 7:16:17 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by 4D Molecular Therapeutics Inc.

    SC 13G/A - 4D Molecular Therapeutics, Inc. (0001650648) (Subject)

    11/14/24 5:46:12 PM ET
    $FDMT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CHEA
    $DMK
    $FDMT
    $INBS
    Financials

    Live finance-specific insights

    View All

    Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year

    First half fiscal 2026 revenue surpasses $2 million, up 36% year-over-year  Reader sales more than double to 104% year-over-year for the second quarter, demonstrating razor-razorblade model momentum Gross profit margins for first half fiscal 2026 increased 10% year-over-year to 49%, reflecting improved operational efficiency Current assets balance of $12.17 million as of December 31, 2025, including $9.40 million receivable in connection with the private placement of securities that closed on January 2, 2026. NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, no

    2/12/26 8:30:00 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    McDONALD'S REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

    Global comparable sales in the fourth quarter increased 5.7%, with positive global comparable guest counts and strong comparable sales growth across all segmentsGlobal Systemwide sales* for the full year increased 7% (5% in constant currencies) to over $139 billion, or growth of $9 billion ($7 billion in constant currencies)Across 70 loyalty markets, Systemwide sales to loyalty members for the full year increased 20% to nearly $37 billion, with 90-day active loyalty users up 19% to nearly 210 million as of year-endCHICAGO, Feb. 11, 2026 /PRNewswire/ -- McDonald's Corporation today announced results for the fourth quarter and year ended December 31, 2025. "McDonald's value leadership is work

    2/11/26 4:01:00 PM ET
    $MCD
    Restaurants
    Consumer Discretionary

    McDONALD'S ANNOUNCES QUARTERLY CASH DIVIDEND

    CHICAGO, Feb. 4, 2026 /PRNewswire/ -- Today, McDonald's Board of Directors declared a quarterly cash dividend of $1.86 per share of common stock payable on March 17, 2026 to shareholders of record at the close of business on March 3, 2026. Upcoming Communications For important news and information regarding McDonald's, including the timing of future investor conferences and earnings calls, visit the Investor Relations section of the Company's Internet home page at www.investor.mcdonalds.com. McDonald's uses this website as a primary channel for disclosing key information to its investors, some of which may contain material and previously non-public information. About McDonald's McDonald's i

    2/4/26 5:00:00 PM ET
    $MCD
    Restaurants
    Consumer Discretionary